Oramed Pharmaceuticals, Inc. (ORMP)
5.355
+0.14
(+2.78%)
USD |
NASDAQ |
Aug 26, 16:00
5.355
0.00 (0.00%)
After-Hours: 16:45
Oramed Pharmaceuticals Debt to Equity Ratio : 0.0023 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0023 |
| March 31, 2026 | 0.0032 |
| December 31, 2025 | 0.0041 |
| September 30, 2025 | 0.0042 |
| June 30, 2025 | 0.0059 |
| March 31, 2025 | 0.0021 |
| December 31, 2024 | 0.0025 |
| September 30, 2024 | 0.0027 |
| June 30, 2024 | 0.0027 |
| March 31, 2024 | 0.1954 |
| December 31, 2023 | 0.3151 |
| September 30, 2023 | 0.5096 |
| June 30, 2023 | 0.0048 |
| March 31, 2023 | 0.0053 |
| December 31, 2022 | 0.0059 |
| September 30, 2022 | 0.0059 |
| June 30, 2022 | 0.0064 |
| March 31, 2022 | 0.0068 |
| August 31, 2021 | 0.0046 |
| May 31, 2021 | 0.0082 |
| February 28, 2021 | 0.0123 |
| November 30, 2020 | 0.0227 |
| August 31, 2020 | 0.0023 |
| May 31, 2020 | 0.0026 |
| February 29, 2020 | 0.0062 |
| Date | Value |
|---|---|
| November 30, 2019 | 0.0062 |
| August 31, 2019 | 0.00 |
| May 31, 2019 | 0.00 |
| February 28, 2019 | 0.00 |
| November 30, 2018 | 0.00 |
| August 31, 2018 | 0.00 |
| May 31, 2018 | 0.00 |
| February 28, 2018 | 0.00 |
| November 30, 2017 | 0.00 |
| August 31, 2017 | 0.00 |
| May 31, 2017 | 0.00 |
| February 28, 2017 | 0.00 |
| November 30, 2016 | 0.00 |
| August 31, 2016 | 0.00 |
| May 31, 2016 | 0.00 |
| February 29, 2016 | 0.00 |
| November 30, 2015 | 0.00 |
| August 31, 2015 | 0.00 |
| May 31, 2015 | 0.00 |
| February 28, 2015 | 0.00 |
| November 30, 2014 | 0.00 |
| August 31, 2014 | 0.00 |
| May 31, 2014 | 0.00 |
| February 28, 2014 | 0.00 |
| November 30, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly & Co. | 1.621 |
| Pfizer Inc. | 0.7418 |
| Yarrow Bioscience, Inc. | 0.00 |
| Liquidia Corp. | 0.9374 |
| NRX Pharmaceuticals, Inc. | -7.329 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 369.64M |
| Total Liabilities (Quarterly) | 52.17M |
| Shareholders Equity (Quarterly) | 317.47M |
| Current Ratio | 4.977 |
| Net Debt Paydown Yield | -0.04% |